Roy Elias - Concepedia

Author

Roy Elias

The University of Texas Southwestern Medical Center ORCID

Also Known As

R Elias, R. Elias, Roy Elias, Roy M. Elias

128

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Texas Southwestern Medical Center Moffitt Cancer Center Advanced Imaging Research (United States)Sylvester Comprehensive Cancer Center

About

Roy Elias is an author at The University of Texas Southwestern Medical Center specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	294
2	Health Sciences	2	2	77
3	Cell Biology	1	1	84
4	Immunology	1	1	46
5	Nephrology	1	1	67

Roy Elias

Publications

678

Citations

H-Index

Page 1

	Year	Citations
An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma Jin Zhou, Jeremy M. Simon, Chengheng Liao, Molecular Cell Epigenetic RegulationMedicineOncogenic AgentOncogenic Jmjd6-dgat1 AxisLipid Droplet Formation	2022	84
Development of <i>o</i>-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors Harshani R. Lawrence, Mathew P. Martin, Yunting Luo, Journal of Medicinal Chemistry	2012	69
Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinoma Nirmish Singla, Roy Elias, Rashed Ghandour, Urologic Oncology Seminars and Original Investigations Surgical OncologyUrologyKidney TransplantGenitourinary CancerMedicine	2019	67
Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab Wungki Park, Deukwoo Kwon, D. Saravia, Clinical Lung Cancer Predictive ModelMedicineCancer ManagementOutcomes ResearchBronchial Neoplasm	2017	65
Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study Ronan T Swords, Diana J. Azzam, Hassan Al‐Ali, Leukemia Research	2017	58
A renal cell carcinoma tumorgraft platform to advance precision medicine Roy Elias, Vanina Toffessi Tcheuyap, Akash Kaushik, Cell Reports	2021	52
Immune-related adverse events are associated with improved outcomes in ICI-treated renal cell carcinoma patients. Roy Elias, Flora Yan, Nirmish Singla, Journal of Clinical Oncology Surgical OncologyCancer ManagementImmunologySelect IraesImmunotherapy	2019	46
Deciphering Intratumoral Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma with a Radiogenomics Platform Durga Udayakumar, Ze Zhang, Yin Xi, Clinical Cancer Research	2021	46
Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma Britney Reese, Ashok Silwal, Elizabeth A. Daugherity, The Journal of Immunology	2020	44
Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma Viral Patel, Roy Elias, Joseph Formella, Journal for ImmunoTherapy of Cancer	2020	30

Page 1